PLTR insider files to sell 21,000 shares valued at $3.5M via Morgan Stanley

Rhea-AI Filing Summary

Palantir Technologies Inc. (PLTR) filed a Form 144 disclosing a proposed sale of 21,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $3,501,540. The shares were acquired on 04/12/2006 from the issuer via previously exercised stock options and payment was in cash. The filing lists the approximate date of sale as 09/11/2025 and the intended exchange as NASDAQ. The filer also reported recent 10b5-1 sales of 800 shares on 07/09/2025 generating $111,688. By signing the notice the seller represents they have no undisclosed material information and, if applicable, that any 10b5-1 plan date is provided.

Positive

• Clear compliance with Rule 144 disclosure requirements and inclusion of 10b5-1 sale details
• Shares are long-held (acquired 04/12/2006 via exercised options), suggesting routine insider liquidity rather than recent acquisition
• Brokered sale through Morgan Stanley Smith Barney on NASDAQ, indicating use of established execution channels

Negative

• Proposed sale value of $3,501,540 could be perceived negatively by some investors as insider selling, despite being immaterial to outstanding shares

Insights

Securities Analyst

TL;DR: Insider intends to sell $3.5M of long-held shares; sale size is immaterial versus outstanding shares.

The filing shows a proposed sale of 21,000 shares valued at $3,501,540 to be executed through Morgan Stanley on NASDAQ. These shares were acquired in 2006 via exercised options and paid in cash, indicating they are long-held and not recently acquired. Relative to the reported outstanding share count of 2,274,261,581, the 21,000-share block represents roughly 0.00092% of shares outstanding, so the transaction is immaterial to market capitalization. Recent 10b5-1 sales of 800 shares on 07/09/2025 produced $111,688, consistent with routine insider liquidity. Overall this Form 144 documents compliance with disclosure obligations but does not indicate a material change to the company’s capital structure.

Compliance & Governance Specialist

TL;DR: Filing is procedural and reflects adherence to Rule 144 and 10b5-1 disclosure requirements.

The notice includes standard attestations regarding absence of undisclosed material information and discloses a plan to sell via an established broker. The seller identifies the acquisition source as previously exercised stock options with a 2006 acquisition date, and notes prior 10b5-1 sales in July 2025. From a governance perspective, the filing demonstrates use of required filing mechanisms and appropriate broker routing. No statements in the form allege any undisclosed adverse information; the document appears compliant and routine.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21000	3501540.00	2274261581	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/12/2006	Previously Exercised Stock Options	Issuer			21000	04/12/2006	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LAUREN STAT 1200 17th Street, Floor 15 Denver CO 80202	Common	07/09/2025	800	111688.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did PLTR disclose on Form 144?

The filer disclosed a proposed sale of 21,000 common shares valued at $3,501,540, to be executed through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of 09/11/2025.

When and how were the shares being sold acquired?

The shares were acquired on 04/12/2006 through previously exercised stock options from the issuer, and payment was in cash.

Has the filer sold shares recently?

Yes. The filing reports 10b5-1 sales of 800 shares on 07/09/2025 that generated $111,688 in gross proceeds.

How large is the proposed sale relative to outstanding shares?

Based on the filing's numbers, 21,000 shares represent approximately 0.00092% of the reported 2,274,261,581 shares outstanding, so the sale is immaterial to total share count.

Does the filing state the seller has any material nonpublic information?

By signing the Form 144, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.